These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17038626)

  • 1. TLRs in the Gut. III. Immune responses to flagellin in Crohn's disease: good, bad, or irrelevant?
    Gewirtz AT
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G706-10. PubMed ID: 17038626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease.
    Gewirtz AT; Vijay-Kumar M; Brant SR; Duerr RH; Nicolae DL; Cho JH
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1157-63. PubMed ID: 16439468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated flagellin-specific immunoglobulins in Crohn's disease.
    Sitaraman SV; Klapproth JM; Moore DA; Landers C; Targan S; Williams IR; Gewirtz AT
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G403-6. PubMed ID: 15388489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLRS in the gut. II. Flagellin-induced inflammation and antiapoptosis.
    Neish AS
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G462-6. PubMed ID: 17082224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flag in the crossroads: flagellin modulates innate and adaptive immunity.
    Gewirtz AT
    Curr Opin Gastroenterol; 2006 Jan; 22(1):8-12. PubMed ID: 16319670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives.
    Devlin SM; Yang H; Ippoliti A; Taylor KD; Landers CJ; Su X; Abreu MT; Papadakis KA; Vasiliauskas EA; Melmed GY; Fleshner PR; Mei L; Rotter JI; Targan SR
    Gastroenterology; 2007 Feb; 132(2):576-86. PubMed ID: 17258734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, visceral fat and Crohn's disease.
    Bertin B; Desreumaux P; Dubuquoy L
    Curr Opin Clin Nutr Metab Care; 2010 Sep; 13(5):574-80. PubMed ID: 20625283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiflagellin antibodies recognize the autoantigens Toll-Like Receptor 5 and Pals 1-associated tight junction protein and induce monocytes activation and increased intestinal permeability in Crohn's disease.
    Lunardi C; Bason C; Dolcino M; Navone R; Simone R; Saverino D; Frulloni L; Tinazzi E; Peterlana D; Corrocher R; Puccetti A
    J Intern Med; 2009 Feb; 265(2):250-65. PubMed ID: 18796002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomedicine. Puzzling out the pains in the gut.
    Marx J
    Science; 2007 Jan; 315(5808):33-5. PubMed ID: 17204619
    [No Abstract]   [Full Text] [Related]  

  • 10. IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin.
    Adams RJ; Heazlewood SP; Gilshenan KS; O'Brien M; McGuckin MA; Florin TH
    Am J Gastroenterol; 2008 Feb; 103(2):386-96. PubMed ID: 17924999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NODs in defence: from vulnerable antimicrobial peptides to chronic inflammation.
    Peyrin-Biroulet L; Vignal C; Dessein R; Simonet M; Desreumaux P; Chamaillard M
    Trends Microbiol; 2006 Oct; 14(10):432-8. PubMed ID: 16942880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella flagellin, a microbial target of the innate and adaptive immune system.
    Salazar-Gonzalez RM; McSorley SJ
    Immunol Lett; 2005 Nov; 101(2):117-22. PubMed ID: 15975666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prototypic disorders of gastrointestinal mucosal immune function: Celiac disease and Crohn's disease.
    James SP
    J Allergy Clin Immunol; 2005 Jan; 115(1):25-30. PubMed ID: 15637543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetics and immunopathogenesis of inflammatory bowel disease.
    Cho JH
    Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of flagellin in Crohn's disease: emblematic of the progress and enigmas in understanding inflammatory bowel disease.
    Vijay-Kumar M; Gewirtz AT
    Inflamm Bowel Dis; 2009 May; 15(5):789-95. PubMed ID: 19107795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal interplay among commensal and pathogenic bacteria: lessons from flagellin and Toll-like receptor 5.
    Rumbo M; Nempont C; Kraehenbuhl JP; Sirard JC
    FEBS Lett; 2006 May; 580(12):2976-84. PubMed ID: 16650409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crohn's disease: the hot hypothesis.
    Peyrin-Biroulet L; Oussalah A; Bigard MA
    Med Hypotheses; 2009 Jul; 73(1):94-6. PubMed ID: 19269107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating theories of the etiology of Crohn's disease. On the etiology of Crohn's disease: questioning the hypotheses.
    Chamberlin WM; Naser SA
    Med Sci Monit; 2006 Feb; 12(2):RA27-33. PubMed ID: 16449960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology of Crohn's disease.
    Braat H; Peppelenbosch MP; Hommes DW
    Ann N Y Acad Sci; 2006 Aug; 1072():135-54. PubMed ID: 17057196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational research in inflammatory bowel disease.
    Abreu MT; Sparrow MP
    Mt Sinai J Med; 2006 Dec; 73(8):1067-73. PubMed ID: 17285196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.